Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-26 12:54 pm Unchanged | 13D | APTOSE BIOSCIENCES INC NO APTO | Hanmi Pharmaceutical Co. Ltd. | 2,989,415 19.02% | 0 (Unchanged) | View |
| 2024-02-02 6:05 pm Purchase | 13D | APTOSE BIOSCIENCES INC NO APTO | Hanmi Pharmaceutical Co. Ltd. | 2,989,415 22.17% | 2,105,263 (+238.11%) | View |
| 2023-09-11 6:23 pm Purchase | 13D | APTOSE BIOSCIENCES INC NO APTO | Hanmi Pharmaceutical Co. Ltd. | 884,152 12.07% | 884,152 (New Position) | View |
| 2022-02-01 4:00 pm Purchase | 13D | SPECTRUM PARMACEUTICALS INC SPPI | Hanmi Pharmaceutical Co. Ltd. | 15,332,331 8.7% | 15,332,331 (New Position) | View |